Investor Lists

Series C biotech investors

Updated 7 November 2026

Firms we have watched take part in a Series C round raised by a biotech company in the last two years. Both the stage and the sector are what they did, not what their website says.

See all 222 →The top 25
222investors on the list+1 this week
5,505cheques in 12 months+3% against the market
$34Mmedian round they joined+325% against the market median
96%wrote a cheque in 12 months
62%have led a round

The Top 25

Ordered by cheques observed, never by anything anyone paid for

Deploying now (25)

  1. 1National Science FoundationDeploying nowGovernment · United States1,869$926Kmedian roundSept 2026last seen
  2. 2Andreessen HorowitzDeploying nowVC firm · United States1,661$27Mmedian roundNov 2026last seen
  3. 3New Enterprise AssociatesDeploying nowVC firm · United States1,610$34Mmedian roundOct 2026last seen
  4. 4General CatalystDeploying nowVC firm · United States1,387$27Mmedian roundNov 2026last seen
  5. 5Lightspeed Venture PartnersDeploying nowVC firm · United States1,341$35Mmedian roundNov 2026last seen
  6. 6BpifranceDeploying nowGovernment · France1,151$4.5Mmedian roundOct 2026last seen
  7. 7Khosla VenturesDeploying nowVC firm · United States1,128$26Mmedian roundNov 2026last seen
  8. 8Founders FundDeploying nowVC firm · United States1,122$15Mmedian roundOct 2026last seen
  9. 9GaingelsDeploying nowPrivate equity · United States1,010$8Mmedian roundOct 2026last seen
  10. 10EIC AcceleratorDeploying nowGovernment · European Union875$4.3Mmedian roundOct 2026last seen
  11. 11Goldman SachsDeploying nowPrivate equity · United States758$73Mmedian roundOct 2026last seen
  12. 12Menlo VenturesDeploying nowVC firm · United States740$37Mmedian roundOct 2026last seen
  13. 13Liquid 2 VenturesDeploying nowVC firm · United States636$7Mmedian roundOct 2026last seen
  14. 14CRVDeploying nowVC firm · United States588$20Mmedian roundOct 2026last seen
  15. 15SVB CapitalDeploying nowVC firm · United States564$20Mmedian roundOct 2026last seen
  16. 16Tengxun TouziDeploying nowVC firm · China553$50Mmedian roundNov 2026last seen
  17. 17U.S. Venture PartnersDeploying nowVC firm · United States535$15Mmedian roundNov 2026last seen
  18. 18Qiming Venture PartnersDeploying nowVC firm · Hong Kong SAR China526$25Mmedian roundOct 2026last seen
  19. 198VCDeploying nowVC firm · United States497$23Mmedian roundOct 2026last seen
  20. 20Mitsubishi UFJ CapitalDeploying nowVC firm · Japan493$4.7Mmedian roundNov 2026last seen
  21. 21Polaris PartnersDeploying nowVC firm · United States490$36Mmedian roundOct 2026last seen
  22. 22Shenzhen Capital Group Co.Deploying nowGovernment · China449$16Mmedian roundOct 2026last seen
  23. 23OrbiMedDeploying nowPrivate equity · United States447$71Mmedian roundOct 2026last seen
  24. 24Lux CapitalDeploying nowVC firm · United States445$30Mmedian roundNov 2026last seen
  25. 25DCVCDeploying nowVC firm · United States431$29Mmedian roundNov 2026last seen
197 more on this list

All 222 are in the app, with filters for stage, sector and market. A free account shows 10 per search, Pro up to 1,000.

See the whole list →

Reading for founders in health and biotech

More books for founders and investors on the Reading List.

As an Amazon Associate we earn from qualifying purchases.

Quick answers about series C biotech investors

Who are the most active series C biotech investors?

By cheques observed, the most active are National Science Foundation, Andreessen Horowitz, New Enterprise Associates, General Catalyst and Lightspeed Venture Partners.

How many series C biotech investors are there?

222 are on record. 96% made an investment in the last 12 months and 62% have led a round.

Which stages do series C biotech investors back?

Of the rounds with a named stage in the last 12 months, mostly Series A (24%) and Seed (21%).

How big are the rounds series C biotech investors join?

The typical (median) round among the leading investors here is $25M.

Which sectors do series C biotech investors back most?

In the last 12 months, mostly AI, Biotech and Healthcare.

Which series C biotech investors lead the most rounds?

Andreessen Horowitz (114 led), General Catalyst (97 led) and Lightspeed Venture Partners (83 led).

Where are series C biotech investors based?

Among the most active, most are based in the United States (19), China (2) and France (1).

What have series C biotech investors invested in recently?

Recent rounds include Arka Fincap (Other, Nov 2026, with TPG), Physicl (Seed, Nov 2026, with U.S. Venture Partners) and Harbinger (Series D+, Nov 2026, with Fidelity).

Built from the rounds we watched, refreshed every night. How we count · Report a correction